{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:34:21Z","timestamp":1776918861614,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51973121"],"award-info":[{"award-number":["51973121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52273299"],"award-info":[{"award-number":["52273299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["GJHZ20210705141800002"],"award-info":[{"award-number":["GJHZ20210705141800002"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220531102207016"],"award-info":[{"award-number":["JCYJ20220531102207016"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515011884"],"award-info":[{"award-number":["2023A1515011884"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bmc.2023.117542","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T11:43:04Z","timestamp":1701862984000},"page":"117542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery of potential scaffolds for glutaminyl cyclase inhibitors: Virtual screening, synthesis, and evaluation"],"prefix":"10.1016","volume":"97","author":[{"given":"Qingqing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feixia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3979-7304","authenticated-orcid":false,"given":"Haiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117542_b0005","doi-asserted-by":"crossref","first-page":"113819","DOI":"10.1016\/j.ejmech.2021.113819","article-title":"Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design","volume":"226","author":"Van Manh","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijbiomac.2020.12.118","article-title":"Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors","volume":"170","author":"Dileep","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2023.117542_b0015","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1523\/JNEUROSCI.1980-20.2020","article-title":"Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation","volume":"41","author":"Rivers-Auty","year":"2021","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117542_b0020","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1021\/acs.jmedchem.2c00335","article-title":"Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease","volume":"65","author":"Padhi","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0025","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00775-018-1605-1","article-title":"The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders","volume":"23","author":"Pozzi","year":"2018","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0030","doi-asserted-by":"crossref","first-page":"10591","DOI":"10.1002\/slct.201902852","article-title":"The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease","volume":"4","author":"Xu","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2023.117542_b0035","doi-asserted-by":"crossref","first-page":"175178","DOI":"10.1016\/j.ejphar.2022.175178","article-title":"Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases","volume":"931","author":"Zhang","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2023.117542_b0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-131535","article-title":"Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-beta Load and Cognitive Decline in Alzheimer's Disease","volume":"39","author":"Morawski","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bmc.2023.117542_b0045","doi-asserted-by":"crossref","first-page":"105770","DOI":"10.1016\/j.intimp.2019.105770","article-title":"Glutaminyl cyclase inhibitor exhibits anti-inflammatory effects in both AD and LPS-induced inflammatory model mice","volume":"75","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bmc.2023.117542_b0050","doi-asserted-by":"crossref","first-page":"105149","DOI":"10.1016\/j.bioorg.2021.105149","article-title":"Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents","volume":"114","author":"Gao","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0055","doi-asserted-by":"crossref","first-page":"104342","DOI":"10.1016\/j.phrs.2019.104342","article-title":"Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease","volume":"147","author":"Vijayan","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2023.117542_b0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/JAD-120517","article-title":"Increased Glutaminyl Cyclase Expression in Peripheral Blood of Alzheimer's Disease Patients","volume":"34","author":"Valenti","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bmc.2023.117542_b0065","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/jm050756e","article-title":"The first potent inhibitors for human glutaminyl cyclase: Synthesis and structure-activity relationship","volume":"49","author":"Buchholz","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117542_b0070","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1021\/jm900969p","article-title":"Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement","volume":"52","author":"Buchholz","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117542_b0075","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1021\/acs.jmedchem.9b00751","article-title":"Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design","volume":"62","author":"Hoang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0080","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1021\/jm4001709","article-title":"Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold","volume":"56","author":"Ramsbeck","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0085","doi-asserted-by":"crossref","first-page":"114837","DOI":"10.1016\/j.ejmech.2022.114837","article-title":"Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents","volume":"244","author":"Van Manh","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0090","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.1021\/acs.jmedchem.7b00648","article-title":"Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease","volume":"60","author":"Li","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/jpet.117.240614","article-title":"Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy","volume":"362","author":"Hoffmann","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2023.117542_b0100","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cbdd.13940","article-title":"Exploring the binding mode of PQ912 against secretory glutaminyl cyclase through systematic exploitation of conformational ensembles","volume":"98","author":"Chandran","year":"2021","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2023.117542_b0105","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1021\/acs.jmedchem.1c00325","article-title":"Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors","volume":"64","author":"Xu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/md20010029","article-title":"Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products","volume":"20","author":"Luo","year":"2021","journal-title":"Mar Drugs"},{"key":"10.1016\/j.bmc.2023.117542_b0115","doi-asserted-by":"crossref","first-page":"115089","DOI":"10.1016\/j.ejmech.2023.115089","article-title":"Design, synthesis and anti-AD effects of dual inhibitor targeting glutaminyl cyclase\/GSK-3beta","volume":"248","author":"Xie","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0120","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1074\/jbc.M110.208595","article-title":"Structures of Human Golgi-resident Glutaminyl Cyclase and Its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding","volume":"286","author":"Huang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0125","doi-asserted-by":"crossref","first-page":"114464","DOI":"10.1016\/j.ejmech.2022.114464","article-title":"Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress","volume":"238","author":"Sang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer's disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2023.117542_b0135","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.3390\/ijms24054367","article-title":"Aducanumab-Hope or Disappointment for Alzheimer's Disease","volume":"24","author":"Wojtunik-Kulesza","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117542_b0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid beta-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2023.117542_b0145","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/jnc.15114","article-title":"Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals","volume":"156","author":"Gunn","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117542_b0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/13543776.2021.1917549","article-title":"A patent review of glutaminyl cyclase inhibitors (2004-present)","volume":"31","author":"Coimbra","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2023.117542_b0155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.compbiolchem.2018.10.016","article-title":"Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6","volume":"77","author":"Uba","year":"2018","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0160","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1039\/D0RA10168K","article-title":"Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists","volume":"11","author":"Zhao","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117542_b0165","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/jm201290v","article-title":"Receptor-ligand interaction-based virtual screening for novel Eg5\/kinesin spindle protein inhibitors","volume":"55","author":"Nagarajan","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117542_b0170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/07391102.2020.1815580","article-title":"Identify thrombin inhibitor with novel skeleton based on virtual screening study","volume":"40","author":"Tang","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2023.117542_b0175","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1080\/07391102.2022.2112080","article-title":"Discovery of novel potential inhibitors of TMPRSS2 and Mpro of SARS-CoV-2 using E-pharmacophore and docking-based virtual screening combined with molecular dynamic and quantum mechanics","volume":"41","author":"Mahgoub","year":"2022","journal-title":"J Biomol Struct Dyn"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:24:13Z","timestamp":1760837053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"alternative-id":["S0968089623003905"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117542","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of potential scaffolds for glutaminyl cyclase inhibitors: Virtual screening, synthesis, and evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117542"}}